Production (Stage)
Black Diamond Therapeutics, Inc.
BDTX
$2.25
$0.2613.07%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 410.24% | 17.64% | 32.38% | -3.95% | 12.69% |
| Total Depreciation and Amortization | 1.16% | -1.16% | -25.22% | -24.56% | -29.51% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 35.26% | 15.27% | -49.16% | 45.02% | -56.97% |
| Change in Net Operating Assets | -15.12% | -120.79% | 99.52% | -83.37% | -64.06% |
| Cash from Operations | 351.95% | -7.87% | 38.33% | -2.49% | -5.83% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -60.00% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 162.14% | 126.64% | 105.67% | -95.89% | -155.37% |
| Cash from Investing | 162.23% | 126.70% | 105.79% | -95.69% | -155.37% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.23% | -- | -- | -- | 7,998.04% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.23% | 732.61% | -100.35% | -- | 7,998.04% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 301.24% | 841.87% | -159.83% | 163.34% | -738.27% |